Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPN10200 for cervical dystonia in adults
2024-519248-34-00Phase 2Authorised
- Sponsor
- Ipsen
- Start
- May 2025
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial in cervical dystonia (CD) comparing IPN10200 with Placebo of IPN10200 (2 arms). Primary endpoint: Change from baseline in TWSTRS total score. Planned start May 2025; status: authorised.
02
Drugs
corabotase
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2024-519248-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519248-34-00.